What sector does Jagsonpal Pharmaceuticals belong to?
Jagsonpal Pharmaceuticals operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.
What is the current share price of JAGSNPHARM?
As of the latest available quote, JAGSNPHARM traded at ₹233.35. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of JAGSNPHARM?
Jagsonpal Pharmaceuticals has a price-to-earnings (P/E) ratio of about 34.78. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of JAGSNPHARM?
The market capitalisation of Jagsonpal Pharmaceuticals is approximately ₹1,536 Cr.
Is Jagsonpal Pharmaceuticals profitable?
For its latest reported financial year, Jagsonpal Pharmaceuticals recorded a net profit margin of about 14.98%.
Does JAGSNPHARM pay a dividend?
Jagsonpal Pharmaceuticals does not currently show a dividend yield in our data.
What is the return on equity (ROE) of JAGSNPHARM?
Jagsonpal Pharmaceuticals has a return on equity (ROE) of about 17.30%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of JAGSNPHARM?
Over the past 52 weeks, JAGSNPHARM has traded between a low of ₹155.00 and a high of ₹264.50.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.